3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
17
Lung Neoplasms
7
Colorectal Neoplasms
6
Neoplasm Metastasis
5
Neoplasms
4
Colonic Neoplasms
3
Pancreatic Neoplasms
2
Carcinoma, Renal Cell
2
Resectable Non-Small Cell Lung Cancer
1
Kidney Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Solid Tumor
1
Interventions
pembrolizumab
15
Nivolumab
9
atezolizumab
5
Ipilimumab
4
Drug Therapy
4
Docetaxel
4
Radiotherapy
3
Radiosurgery
3
Paclitaxel
3
Gemcitabine
3
Cetuximab
3
Carboplatin
3
Blood Specimen Collection
3
temsirolimus
2
spartalizumab
2
sargramostim
2
motexafin gadolinium
2
liposomal doxorubicin
2
entinostat
2
durvalumab
2
belinostat
2
Sirolimus
2
Psychiatric Rehabilitation
2
Peripheral Blood Stem Cell Transplantation
2
Metformin
2
Irinotecan
2
Fluorouracil
2
Etoposide
2
Dexamethasone
2
Cyclophosphamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
adagrasib
×
Thoracic
×
Clear all
NCT06026410
2026-04-14
FIT-001
Kura Oncology, Inc.
Phase 1
Recruiting
300 enrolled